Literature DB >> 22400153

From biodefence to biosecurity: the Obama administration's strategy for countering biological threats.

Gregory D Koblentz1.   

Abstract

The Seventh Review Conference of the Biological Weapons Convention (BWC), the first international treaty to outlaw an entire class of weapons, was held in Geneva in December 2011. On 7 December, Secretary of State Hillary Clinton became the highest-ranking US government official to address a BWC meeting. Secretary Clinton told the assembled delegation that ‘we view the risk of bioweapons attack as both a serious national security challenge and a foreign policy priority’. At the same time, she warned that a large-scale disease outbreak ‘could cripple an already fragile global economy’. Secretary Clinton's speech reflected a new understanding that the range of biological threats to international security has expanded from state-sponsored biological warfare programmes to include biological terrorism, dual-use research and naturally occurring infectious diseases such as pandemics. Recognizing these changes, President Barack Obama released a new national strategy for countering biological threats in 2009. This strategy represents a shift in thinking away from the George W. Bush administration's focus on biodefence, which emphasized preparing for and responding to biological weapon attacks, to the concept of biosecurity, which includes measures to prevent, prepare for and respond to naturally occurring and man-made biological threats. The Obama administration's biosecurity strategy seeks to reduce the global risk of naturally occurring and deliberate disease outbreaks through prevention, international cooperation, and maximizing synergies between health and security. The biosecurity strategy is closely aligned with the Obama administration's broader approach to foreign policy, which emphasizes the pragmatic use of smart power, multilateralism and engagement to further the national interest. This article describes the Obama administration's biosecurity strategy; highlights elements of continuity and change from the policies of the Bush administration; discusses how it fits into Obama's broader foreign policy agenda; and analyses critical issues that will have to be addressed in order to implement the strategy successfully.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22400153     DOI: 10.1111/j.1468-2346.2012.01061.x

Source DB:  PubMed          Journal:  Int Aff        ISSN: 0020-5850


  4 in total

1.  Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework.

Authors:  Raul V Destura; Hilton Y Lam; Rohani C Navarro; Jaifred Christian F Lopez; Reneepearl Kim P Sales; Ma Ida Faye A Gomez; Angelo Dela Tonga; Gianne Eduard Ulanday
Journal:  Appl Biosaf       Date:  2021-11-24

Review 2.  Global health diplomacy-reconstructing power and governance.

Authors:  Ilona Kickbusch; Austin Liu
Journal:  Lancet       Date:  2022-05-17       Impact factor: 202.731

Review 3.  Biopreparedness in the Age of Genetically Engineered Pathogens and Open Access Science: An Urgent Need for a Paradigm Shift.

Authors:  C Raina MacIntyre
Journal:  Mil Med       Date:  2015-09       Impact factor: 1.437

4.  Human security as biosecurity Reconceptualizing national security threats in the time of COVID-19.

Authors:  Craig Albert; Amado Baez; Joshua Rutland
Journal:  Politics Life Sci       Date:  2021-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.